| Join
the SmallCapReview mailing list |
 |
|
| Small
Cap Stocks On The Radar
|
| MJNA
Medical Marijuana:
The first publicly held company
vested in the medical marijuana and industrial hemp markets. The company is
comprised of a diversified portfolio of products, services, technology and
businesses solely focused on the cannabis and hemp industries. Reported
First Quarter earned net income of
approximately $1.21 million.
More. |
| CLDX
Celldex Therapeutics: The first antibody-based combination immunotherapy company. Celldex has a
pipeline of drug candidates in development for the treatment of cancer and
other difficult to treat diseases based on its antibody focused Precision
Targeted Immunotherapy (PTI) Platform.
More. |
| CRUS
Cirrus Logic:
The leader in converged
networking solutions, providing enterprise-class connectivity for
servers, networks and storage devices within the data center. Emulex solutions are used by the
industry's leading server and storage OEMs including, Cisco, Dell,
EMC, Fujitsu, Hitachi, Hitachi Data Systems, HP, Huawei, IBM, NEC,
NetApp and Oracle.
More. |
| OSUR
OraSure Technologies: A
leader in the development, manufacture and distribution of oral
fluid diagnostic and collection devices and other technologies
designed to detect or diagnose critical medical conditions.
(FDA) Blood Products
Advisory Committee provided a unanimous positive recommendation for the
Company's OraQuick(R) In-Home HIV Test.
More. |
| ZUMZ
Zumiez:
Operates as a
leading specialty retailer of action sports related apparel,
footwear, equipment and accessories operating under the Zumiez brand
name. As of July 30, 2011, the Company operated 424 stores primarily
located in shopping malls, giving them a presence in 38 states and
Canada. More. |
| VELT
Velti: A leading global provider of mobile marketing and advertising technology
and solutions that enable brands, advertising agencies, mobile operators and
media to implement highly targeted, interactive and measurable campaigns by
communicating with and engaging consumers via their mobile devices.
More. |
|
|
|
Where Small Cap Stocks Thrive Since
1999
Grassroots
Research Publishes Research Report On Medical Marijuana Inc., With A Buy
Rating and A Cohen Price Target...(MJNA)
The
report projects
revenues of approximately $3.8 million in 2012 and $100.06 million in 2017.
Margins are likely to expand with the Company increasing its production
capacity.
The Current price target for the
stock is $0.18 an over 300% increase from Tuesday's closing price of $0.054.
Medical
Marijuana (MJNA)

Website:
www.MedicalMarijuanaInc.com
"In the First
Quarter The Company Earned Net Income of Approximately $1.21 Million on
Gross Revenues of $1.79 Million. That's an Increase of over 400% from Last
Quarter and an Accumulative 12,000% plus Increase in Revenue since the same
Quarter Last Year."
MJNA
Investor Highlights
-
Earnings Up 400% -
In the
first quarter the company earned net income of
approximately $1.21 million on gross revenues of $1.79 million for the
quarter ended March 31, 2012. That's an increase of over 400% from last
quarter and an accumulative 12,000% plus increase in
revenue since the same quarter last year.
-
Acquisitions -
Acquired
two additional Wellness
Managed Services accounts which will generate estimated annual
revenues of $1.7 million.
-
Completed the acquisition of Dixie Elixirs & Edibles brand,
intellectual property, proprietary formulas and extraction processes. In
conjunction it formed Red Dice Holdings, as was announced in late April,
to develop manufacturing and distribution partnerships for Dixie in
every state and country that has legalized medical cannabis.
-
Expansion - Begun hemp-based
extraction product development beyond the medical marijuana industry,
crossing into the nationally legal category of health and wellness with
such products as sleep aids, topical and pain management. A market
launch of the new products is expected by the end of the second quarter.
-
Brought PhytoSPHERE systems on-line and will begin to market the
benefits of its seed-to-sale product growth and cultivation technology
in an attempt to secure licensing agreements worldwide.
-
Growth - The Company has
built additional raw ingredients supply sources on four continents in
preparation for international expansion and it continues to develop
international sales and distribution channels for its high-value
extracts and compounds and related products produced by Dixie Elixirs
and Edibles.
-
Medical Marijuana, Inc.'s Wellness Managed Services (WMS) division
plans to expand internationally to provide additional clinics, doctor's
offices and wellness centers under the WMS umbrella.
-
PhytoSPHERE plans to develop and launch a national/international
marketing campaign in the third quarter to support sales of licensing
agreements for its proprietary indoor planting, cultivation and
extraction technology.
-
Medical Marijuana, Inc. plans to establish a "Raw Ingredients
Division" by the third quarter to provide raw ingredients and
production services to other cannabis-based businesses.
-
"With 16 states and Washington, D.C. allowing for legal use of medical
marijuana and twelve more states with legalization initiatives on the
ballot, MJNA is confident that the opportunity for continued growth in the
US is exceptional.
-
Equally as important is the growing movement towards decriminalization
outside the US and across Europe, which will allow MJNA to leverage what
they
have learned in mature legalized states like Colorado and California, and
apply it to international markets. MJNA sees opportunity for significant
national and international expansion by the end of 2012.
-
Strong Backing -
Cannabank, the private equity group that
finances and incubates early stage acquisitions for MJNA, has agreed to
finance several key transactions for the company including the European
based pharmaceutical firm previously announced.
-
Secured $4 million in non-dilution, non-recourse finance for the
acquisition and development of strategic acquisitions.
-
Moving on Up -
Commenced the
first step in the process for its 15c2-11 filing status with BMA
Securities. The filing is the company's securities to be quoted on the
National Association of Securities Dealers' ("NASD")
Over-the-Counter Bulletin Board ("OTCBB"). Once approved, this
filing status causes another level of transparency which will be
attractive to additional market makers and brokerage firms, thereby
providing increased visibility to a broader set of investors.
-
Shareholder Value - Retired 14,600,000 shares worth
approximately $1.0 million dollars.
-
Closed a $1.04 million upfront payment licensing transaction for high
value hemp extracts.
-
Intellectual Property -
The Company is aggressively pursuing the acquisition and filing of
additional product patents.
-
Enormous Industry - Medical
Marijuana and Industrial Hemp have over 55,000 known uses, all of which
are under developed, undercapitalized and underutilized. It has been
estimated that marijuana in the United States alone is a $110 billion
market and the medical market makes up nearly $17 billion. Today the
market is fractured in terms of international, state and local laws as
well as with the business and people who participate in the industry. In
our opinion, this is where MJNA, with its solid corporate structure,
affords shareholders the biggest opportunity to profit.
Overview
Medical Marijuana Inc. (“MJNA”) is the first publicly held company
vested in the medical marijuana and industrial hemp markets. The company is
comprised of a diversified portfolio of products, services, technology and
businesses solely focused on the cannabis and hemp industries.
These products range from patented and proprietary based cannabinoid
products, to whole plant or isolated high value extracts specifically
manufactured and formulated for the pharmaceutical, nutraceutical and
cosmeceutical industries.
The Company’s services are extensive and varied, ranging from medical
clinic management to the capitalization and development of existing industry
business and product leaders. Services include development of cannabinoid
based health and wellness products, and the development of medical grade
compounds. MJNA provides over 50 proprietary and patented cannabinoid
“delivery methods” that are more “socially and medically acceptable”
than smoking. Finally, MJNA services include the licensing of its
proprietary testing, genetics, labeling, and packaging, tracking, production
and standardization methods for the medicinal herb industry.
Medical Marijuana Inc.’s patented and proprietary technologies include
the only pharmaceutical grade vertical Bio-Technology Company specializing
in the standardization, production and extraction of medicinal cannabinoids.
MJNA’s PhytoSPHERE Systems and their advanced plant growth technologies
save significantly on resources necessary for production of medical grade
cannabis. In addition to providing a medical grade end product, extracts and
compounds, PhytoSPHERE Systems also includes pre-and-post production
tracking, gemplasm references, packaging and processing to ensure
consistency and genetic purity.
Profile
Medical
Marijuana's (MJNA) mission is to be the premier cannabis and hemp
industry innovators, leveraging its team of professionals to source,
evaluate and purchase value-added companies and products, while allowing
them to keep their integrity and entrepreneurial spirit. MJNA strives to
create awareness within the industry, develop environmentally friendly,
economically sustainable businesses, while increasing shareholder value.
The company earned net income of approximately $1.21
million on gross revenues of $1.79 million for the quarter ended March 31,
2012. This represents a gross revenue increase of 400 plus percent
quarter-over-quarter when compared to revenue of $430,000 for the quarter
ended December 31, 2011 and an accumulative 12,000 plus percent increase in
revenue since the same quarter last year. Operating expenses were
approximately $580,000 for the quarter.
|
Quarterly
|
|
Three months ended
Mar. 31, 2011
|
Three months ended
Jun. 30, 2011
|
Three months ended
Sept. 30, 2011
|
Three months ended
Dec. 31, 2011
|
Three months ended
Mar. 31, 2012
|
|
Revenue
|
$20,426
|
$196,748
|
$198,813
|
$430,140
|
$1,788,445
|
|
Assets
|
$74,376
|
$568,116
|
$1,443,251
|
$1,948,165
|
$6,356,301
|
|
Debt
|
$73,403
|
$103,464
|
$14,879
|
$26,785
|
$101,778
|
|
Net Income
|
($42,613)
|
($1,292,722)
|
($1,067,473)
|
($62,711)
|
$1,208,136
|
Recent
News and Press Releases
Grassroots
Research Publishes Research Report On Medical Marijuana Inc., With A Buy
Rating and A Cohen Price Target
Medical
Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and
Future Development. First Audio-Webcast Interview With SmallCapVoice.com in
Quarterly Series
Medical
Marijuana, Inc. Submits Updated 15c2-11 Filing
Medical
Marijuana, Inc. Announces First Quarter 2012 Results
Dixie
Elixirs & Edibles and PhytoSPHERE Systems, Portfolio Companies of
Medical Marijuana, Inc, Grow Relationship with New Licensing Agreement
Medical
Marijuana, Inc.’s Dixie Elixir and Edibles Brand to Launch First
non-THC-Based Line of Health and Wellness Products
Medical
Marijuana Inc (OTC: MJNA) Announces Its Wholly Owned Subsidiary Wellness
Managed Services Signs An Additional Management Contract Increasing Annual
Revenue By $1,700,000, Quarter Over Quarter Revenue Increase On Pace To
Maintain 100% Compounded Quarterly
Medical
Marijuana, Inc. and Dixie Elixirs Strike Innovative Agreement to Extend
Dixie Elixirs Brand to Other MMJ Legal States
Medical
Marijuana Inc. (OTC: MJNA) Acquires 80% of PhytoSPHERE Systems, LLC, A
Leading Biotechnology Company Specializing in Pharmaceutical Grade Cannabis
Compounds and Extracts
For the latest Quote
and News on MJNA Click
Here.
Outlook
Michael Llamas, President of
Medical Marijuana comments on the Company's outlook.
"The first quarter of 2012 brought into clear focus all that we have
been working towards since Cannabank's initial investment into Medical
Marijuana, Inc. about a year ago," said Michael Llamas, President of
Medical Marijuana, Inc. "We have spent this last year essentially
getting our house in order by clarifying the growth strategy and
systematically identifying, acquiring and growing early stage companies
across the spectrum of the MMJ industry from product development to retail
sales. As witnessed by our strong quarter-over-quarter and
year-over-year growth, there is tremendous opportunity in this industry. We have the capital and the systems in place to buy, incubate and grow the
best companies across multiple categories within the industry. At the same
time, there is aggressive natural attrition of other companies and whole
categories as the industry right sizes itself-which creates further
opportunities and differentiation for Medical Marijuana, Inc. this truly is
the perfect storm for acquiring income producing businesses.
"However, we also know that a 12,000 percent year-over-year growth
is decidedly a factor of where we are in our growth cycle. We won't always
have such favorable comparables moving forward past our second year. We do
expect the comparable growth to normalize, but more importantly, we expect
continued healthy growth in our core businesses as they begin to mature and
the industry stabilizes. I'm equally proud that we have been able to
maintain this rapid growth with a small core of dedicated and truly
innovative employees and as a result, our operating costs have begun to
stabilize since the close of the fourth quarter. We anticipate continued
cost efficiency in line with future growth."
"With 16 states and Washington, D.C. allowing for legal use of medical
marijuana and twelve more states with legalization initiatives on the
ballot, we are confident that the opportunity for continued growth in the
US, regardless of state boundaries, is exceptional," added Llamas.
"Equally as important is the growing movement towards decriminalization
outside the US and across Europe, which will allow us to leverage what we
have learned in mature legalized states like Colorado and California, and
apply it to international markets. We see opportunity for significant
national and international expansion by the end of 2012 and we are currently
putting in place the necessary supply chain and infrastructure elements to
best position Medical Marijuana, Inc. and our shareholders to benefit from
this growth."
Operations
PhytoSPHERE Systems LLC
PhytoSPHERE Systems, a subsidiary of MJNA, is a biotechnology company with an exclusive
licensed, patented technology to build highly efficient vertical growth
systems in compact, safe, pollutant free facilities throughout the US, while producing plant-based biocompounds in
other countries that permit the cultivation and production of hemp and
medical marijuana. This state of the art
technology is fully contained, which means crops can be grown year round
in any location using precise combinations of light, water, and nutrients to
maximize production.
Utilizing the TerraSphere System and its’ own
state-of-the art proprietary extraction, purification, quality control and
packaging processes, PhytoSPHERE Systems can assure its customers a
reliable, consistent supply of high quality plant based compounds such as
high value hemp oil, CBD,, plus numerous other cannabinoids.
MJNA plans on building PhytoSPHERE facilities in countries that legally allow the
cultivation of hemp for medical benefits. A major concern for sellers of
natural product drugs, medical herbs, nutraceuticals, and cosmeceuticals is
the unreliable supply of top quality active ingredients. Cultivation of
source plants is erratic and the quality of extracts is highly uneven. With
PhytoSPHERE MJNA can establish itself as the leading company serving this
exploding market.
Dixie Elixir & Edibles
MJNA's, portfolio company, Red Dice Holdings, LLC, owns the exclusive rights to
license the Dixie Elixirs & Edibles
brand, consisting of more than forty medicinal
hemp-based infused products including medicated beverages and tonics,
pharmaceutical grade hemp capsules, medicated lozenges and edibles, as well
as a full line of topicals and salves as part of the Dixie Botanicals line
of products which was recently featured on National Geographic's series American
Weed.
As one of the world's most recognized medicinal hemp infused brands, Dixie
products are distributed currently in over 400 retail locations in Colorado alone and will be expanding rapidly
to other states that allow for medical cannabis. Red Dice Holdings, LLC
through its Dixie brand focuses on the development of innovative medically and socially acceptable delivery systems.
Red Dice
Holdings, LLC is licensing its proprietary formulas, manufacturing and extraction technology and delivery
systems to other socially conscious companies in an effort to rapidly expand its distribution base. Currently, 16 states plus Washington DC have legalized the use of medical
cannabis products.
HempMeds RX
MJNA's Hemp Med Rx division is the world’s premier developer of specialty health
and wellness products derived from Hemp extracts and compounds. In a recent
press release, MJNA announced HepMeds RX would begin selling three new
Cannabidiol (CBD) products in association with Dixie Elixirs. These products
will contain significant quantities of high concentration CBD hemp oil while
containing zero THC.
By August 2012, MJNA intends to launch a mail order campaign and online
e-commerce platform that will allow individuals throughout the U. S. to
purchase these products since they contain no THC. The U. S. availability
will be followed closely by distribution in international markets including
Europe via several key product distribution relationships that are currently
under negotiation.
This is a huge opportunity for MJNA to
generate substantial revenue, and for investors to make big profits from the
stock.
Wellness Managed Services
MJNA’s Wellness Managed Services manages and develops Health and Wellness
facilities throughout North America. Wellness Managed Services will provide
patients with the finest Cannabidiol (CBD) products for health and wellness,
as well as providing ancillary services for the facility in terms of
tracking, accounting, patient management, insurance reimbursement (where
applicable), merchant processing and other services.
Since the end of the 4th quarter 2011, Wellness Managed Services has actively been
acquiring and developing its services. This subsidiary is in negotiations for several additional facilities in Canada,
California, Colorado and Arizona at present and is looking to further expand
throughout the US as well as develop an International Division. With the
execution of the large contract announced on April 24th, Wellness Managed
Services will begin to integrate the MJNA Portfolio of products and services
toward the various facilities in our system.
Ace Hydro
Ace Hydro, a division of MJNA, is a start-up business that will acquire existing
hydroponic businesses nationwide. MJNA will integrate these businesses into
the Ace Hydro brand, thereby lowering operating costs and providing these
retailers with unmatched support and competitive advantages. Under the Ace
Hydro umbrella, retailers can expect lower overhead, greater economic
security, future financing, and expansion opportunities, all while retaining
the ability to manage the store’s daily operations.
MMI Nutraceuticals
MMI Nutraceuticals is a subsidiary of Medical Marijuana Inc. that deals in many
different types of products that include CBD (Cannabidiol) and THC Free
brands. Nutraceutical is defined as a dietary supplement providing health
benefits along with basic nutritional value. MMI Nutraceuticals has 50 patented, proprietary
technologies and socially acceptable delivery methods.
MMI Biotechnology
MMI Biotechnology manufactures and builds specialty equipment
and technology for the pharmaceutical, medical herbal and the nutraceutical
industry. It does so by engaging in the acquisition of companies and
business units, which manufacture or build biotechnology and equipment,
serving the need for hemp agricultural and medicinal technology market. MMI
Biotechnology has been licensed by the Hemp Deposit and Distribution
Corporation for the whole of the western hemisphere.
More
o n
MJNA here...
SmallCapReview
Initiates Coverage of Medical Marijuana (MJNA)...
Why
Small Caps Will See You Through The Recession...
Timing
And Microcaps...
Small
Caps Paying Dividends...
15
Sites For Finding Deals Online...
Per
Capita Personal Income By State....
The
Secret $15 Billion Road Tax...
Poorly maintained roads are costing drivers plenty in repairs, and it doesn't
look as if relief is coming any time soon. 
Booze,
Guns, Gambling... Sinful
stocks for a recession proof portfolio.
Blame
Reckless Banks For Trouble With Greece...
The
Most Dangerous States To Drive In...
5
Top Small Caps Boast Big Earnings...
6
Microcaps Trading For Less Than Cash...
9
Profitable Small Caps Targeted To Grow...
4
Small Caps Under $5 With Bullish Trends...
Which
States Are The Most Money Savvy...
Top
10 Dow Dividend Stocks...
Oil
Boom Strikes Kansas...
True
Cost To Own Your Make And Model Car...
Managing
Through Microcap Mania...
High-Risk,
High-Reward Small Cap Stocks...
The
Strongest Small Caps In The Market...
Celldex
Therapeutics (CLDX)

"Preliminary
results from the Company’s randomized Phase 2b study suggest that CDX-011
induces impressive response rates compared to current, available therapies
in patients with advanced, refractory breast cancers."
More
on CLDX here...
OraSure
Technologies (OSUR)

"Received
a unanimous positive
recommendation for the Company's OraQuick(R) In-Home HIV Test
from the U.S. Food and
Drug Administration (FDA)
Blood Products Advisory Committee."
More
on OSUR here...
Velti
(VELT)

"Announced
First Quarter revenue of $51.8 million, growth of 75%, compared to Q1
2011."
More
on VELT here...
Cirrus
Logic (CRUS)

" Cirrus Logic has more than 1,000 patents that are key to more
than 700 products serving more than 2,500 end customers globally."
More
on CRUS here...
Zumiez (ZUMZ)

"A
Leading Specialty Retailer Of Action Sports Related Apparel."
More on ZUMZ here...
Follow Us
On

|